Vanqua Bio

Chicago, IL · Founded 2019 · Privately Held (backing)

Operator of a biopharmaceutical company intended to discover and develop next-generation medicines for neurodegenerative diseases. Vanqua Bio is based in Chicago, IL and was founded in 2019. Its last known valuation is $270 million. It has raised $149 million across 2 recorded rounds; the latest was a $45 million early-stage round in Feb 2024.

Last price · $/share
—
Implied valuation
$270.0M
Total raised
$149.0M
Last round
Early Stage VC
Feb 2024
Cap table — not yet on record

Vanqua Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vanqua Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Vanqua Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Vanqua Bio

Where does Vanqua Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vanqua Bio's 2 recorded funding rounds.